In the US, we are a top three player by volume in generic injectable medicines and have a strong presence in the non-injectable generics market. We are putting better health within reach through a range of therapeutic categories. These include respiratory, oncology, and pain management. With three regulatory-compliant manufacturing facilities in the country, we are the sixth largest generic medicines manufacturer in the US.
Hikma in the US in numbers
200generic injectable products
109non-injectable generic products
200experienced R&D employees